Biocon Chairperson Kiran Mazumdar-Shaw highlights India's massive potential in the genomics space, a sector that gained critical prominence during the COVID-19 pandemic. Speaking at the launch of Mapmygenome's Genomics Experience Center in Bengaluru, she emphasizes how genomic sequencing has revolutionized diagnostic testing, vaccine development, and therapeutics. Shaw underscores the rising importance of preventive genomics—combining DNA sequencing with biochemistry—and ancestral genomics in shaping the future of Indian healthcare.
"The pandemic has clearly shown us the need for genomic expertise. Without genomic sequencing, we would not even have the sequence of the Covid-19 virus, which led to the production of diagnostic tests and vaccines..." > India is standing on the brink of a massive genomic revolution. From tracking genetically borne diseases in mothers and children to pioneering ancestral and preventive genomics, discover how Indian innovators are blending biochemistry and DNA technology to transform healthcare.
iran Mazumdar-Shaw highlighted several key points praising the company's role in the healthcare ecosystem:
-
Pioneering the Genomic Revolution: She stated that companies like Mapmygenome are at the absolute forefront of India's genomic revolution.
-
Advancing Preventive Healthcare: She lauded Mapmygenome's expansion into preventive genomics, emphasizing how powerful it is to combine genomic sequencing with lifestyle and preventive biochemistry.
-
Crucial Focus on Maternal & Child Health: Mrs. Shaw pointed out the importance of the company's next-generation sequencing initiatives for mothers and children, noting they are vital for understanding and tracking genetically borne diseases early on.
-
Spearheading Ancestral Genomics: She highlighted ancestral genomics as a fascinating subject that Mapmygenome has successfully spearheaded in India, predicting that many other companies will eventually follow their lead.
